Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
about
Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.Emerging targeted drug therapies in skeletal dysplasias.An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans ProgressivaPalovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity
P2860
Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@en
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@nl
type
label
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@en
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@nl
prefLabel
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@en
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@nl
P2093
P2860
P1433
P1476
Effectiveness and mode of acti ...... nd an anti-inflammatory agent.
@en
P2093
Kenta Uchibe
Masahiro Iwamoto
Maurizio Pacifici
Sayantani Sinha
P2860
P356
10.1016/J.BONE.2016.02.008
P577
2016-02-15T00:00:00Z